Jason Mills

Robotic surgical system manufacturer Intuitive Surgical, Inc. (NASDAQ: ISRG) reported above-consensus second-quarter results Thursday.  The Analysts Canaccord Genuity analyst Jason Mills maintained a Buy rating on Intuitive Surgical and lifted the price target from $575 to $610. Stifel...

Edwards Lifesciences Corp (NYSE: EW) reported Tuesday after the market close with above-consensus first-quarter results and raised its adjusted earnings per share guidance for the full year. The Analysts UBS analyst Matthew Taylor maintained a Neutral rating on Edwards with a $190...

Prior to a big bounce Wednesday morning, Nevro Corp (NYSE: NVRO) stock was down nearly 50 percent in the past month. Much of the drop came Tuesday following what the market perceived as bad news tied to the company’s patent dispute with Boston Scientific Corporation (NYSE...

Medical device manufacturer Nevro Corp (NYSE: NVRO)'s shares are tumbling after the company's first-quarter report after the close Monday.  Nevro reported a wider-than-expected loss of 51 cents per share and below-consensus revenue for the quarter, while it reiterated its full-...

Canaccord Genuity said in a Tuesday note Boston Scientific Corporation (NYSE: BSX) enjoys the most robust pipeline in its long, storied history. The firm also said the company is set to further augment the proportion of sales derived from faster-growth markets, many of which sport tailwinds. The...

Looking for a compelling reason to buy shares of Edwards Lifesciences Corp (NYSE: EW)? Here are three reasons, courtesy of Search Results Canaccord Genuity's Jason Mills. Shares of Edwards were trading higher by nearly 9 percent on Wednesday and hit an intra-morning high of $113.04 following the...

Canaccord released a new bullish note on Intuitive Surgical, Inc. (NASDAQ: ISRG) after its better-than-expected quarterly results, saying the company is “shaping up to be one of the most compelling large-cap med-tech stocks in the sector.” Analyst's Commentary Analyst Jason Mills...

The quiet period surrounding Irhythm Technologies Inc (NASDAQ: IRTC)'s stock has now ended after its fantastic IPO debut, so research firms are free to now evaluate the stock and issue their opinions. Here is a summary of some of the research reports, which were made available for the first time on...

Canaccord Genuity has raised its price target on the shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by $50 to $750 after the firm's blowout second-quarter print. "We expect the stock to trade materially higher, as we are increasingly confident robotic-assisted surgery devices (RASD) are in the...

Shares of Endologix, Inc. (NASDAQ: ELGX) rose more than 6 percent after Canaccord Genuity upgraded the stock to Buy from Neutral, saying that the Nellix "carrot" could be the key driver both this year and next. Nellix is an investigational EndoVascular Aneurysm Sealing (EVAS) system designed for...

Canaccord Genuity said Intuitive Surgical, Inc. (NASDAQ: ISRG) has ample runway for growth despite Medtronic PLC (NYSE: MDT)'s push on robotic surgery. The brokerage reiterated its Buy rating and $700 price target on the ISRG shares following Medtronic's investor and analyst meeting...